Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Rattus norvegicus | Acyl coenzyme A:cholesterol acyltransferase 1 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | Get druggable targets OG5_133487 | All targets in OG5_133487 |
Schistosoma mansoni | sterol O-acyltransferase 1 | Get druggable targets OG5_133487 | All targets in OG5_133487 |
Loa Loa (eye worm) | hypothetical protein | Get druggable targets OG5_133487 | All targets in OG5_133487 |
Echinococcus granulosus | sterol O acyltransferase 1 | Get druggable targets OG5_133487 | All targets in OG5_133487 |
Echinococcus multilocularis | sterol O acyltransferase 1 | Get druggable targets OG5_133487 | All targets in OG5_133487 |
Schistosoma japonicum | ko:K00637 sterol O-acyltransferase [EC2.3.1.26], putative | Get druggable targets OG5_133487 | All targets in OG5_133487 |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Neospora caninum | sterol O-acyltransferase, putative | Acyl coenzyme A:cholesterol acyltransferase 1 | 545 aa | 510 aa | 21.2 % |
Toxoplasma gondii | acyl-CoA:cholesterol acyltransferase alpha ACAT1-alpha | Acyl coenzyme A:cholesterol acyltransferase 1 | 545 aa | 510 aa | 24.1 % |
Dictyostelium discoideum | diacylglycerol O-acyltransferase 1 | Acyl coenzyme A:cholesterol acyltransferase 1 | 545 aa | 547 aa | 22.3 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | Ets-domain containing protein | 0.0082 | 0.1207 | 0.1863 |
Loa Loa (eye worm) | fli-1 protein | 0.0248 | 0.609 | 0.8457 |
Loa Loa (eye worm) | hypothetical protein | 0.0056 | 0.0446 | 0.0487 |
Echinococcus granulosus | geminin | 0.0191 | 0.4421 | 0.4421 |
Schistosoma mansoni | hypothetical protein | 0.0191 | 0.4421 | 0.6736 |
Schistosoma mansoni | chromobox protein | 0.0079 | 0.1116 | 0.1701 |
Echinococcus granulosus | GA binding protein alpha chain | 0.0082 | 0.1207 | 0.1207 |
Schistosoma mansoni | chromobox protein | 0.0079 | 0.1116 | 0.1701 |
Entamoeba histolytica | carbonic anhydrase, putative | 0.0241 | 0.5887 | 1 |
Brugia malayi | chromobox protein homolog 3 | 0.0044 | 0.0102 | 0.0157 |
Echinococcus granulosus | chromobox protein 1 | 0.0079 | 0.1116 | 0.1116 |
Echinococcus multilocularis | chromobox protein 1 | 0.0079 | 0.1116 | 0.1116 |
Loa Loa (eye worm) | hypothetical protein | 0.0238 | 0.5805 | 0.8054 |
Schistosoma mansoni | gabp alpha | 0.0082 | 0.1207 | 0.1839 |
Loa Loa (eye worm) | follicle stimulating hormone receptor | 0.0261 | 0.648 | 0.9007 |
Schistosoma mansoni | carbonic anhydrase | 0.0241 | 0.5887 | 0.8971 |
Brugia malayi | Ets-domain containing protein | 0.0082 | 0.1207 | 0.1863 |
Leishmania major | carbonic anhydrase family protein, putative | 0.0241 | 0.5887 | 0.5 |
Mycobacterium leprae | CARBONIC ANHYDRASE (CARBONATE DEHYDRATASE) (CARBONIC DEHYDRATASE) | 0.0241 | 0.5887 | 0.5 |
Schistosoma mansoni | ets-related | 0.0248 | 0.609 | 0.928 |
Mycobacterium ulcerans | carbonic anhydrase | 0.0241 | 0.5887 | 1 |
Echinococcus multilocularis | GA binding protein alpha chain | 0.0082 | 0.1207 | 0.1207 |
Loa Loa (eye worm) | hypothetical protein | 0.007 | 0.0859 | 0.1069 |
Brugia malayi | follicle stimulating hormone receptor | 0.0261 | 0.648 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0285 | 0.7183 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0264 | 0.6563 | 0.9124 |
Echinococcus granulosus | sterol O acyltransferase 1 | 0.0264 | 0.6563 | 0.6563 |
Echinococcus multilocularis | chromobox protein 1 | 0.0079 | 0.1116 | 0.1116 |
Echinococcus granulosus | chromobox protein 1 | 0.0079 | 0.1116 | 0.1116 |
Echinococcus multilocularis | tumor protein p63 | 0.0381 | 1 | 1 |
Schistosoma mansoni | sterol O-acyltransferase 1 | 0.0264 | 0.6563 | 1 |
Trichomonas vaginalis | chromobox protein, putative | 0.0079 | 0.1116 | 0.5737 |
Brugia malayi | Heterochromatin protein 1 | 0.0079 | 0.1116 | 0.1722 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0104 | 0.187 | 1 |
Schistosoma mansoni | cellular tumor antigen P53 | 0.0056 | 0.0446 | 0.068 |
Loa Loa (eye worm) | D-ets-4 DNA binding domain-containing protein | 0.0082 | 0.1207 | 0.1561 |
Mycobacterium tuberculosis | Beta-carbonic anhydrase CanB | 0.0137 | 0.2826 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0191 | 0.4421 | 0.6736 |
Onchocerca volvulus | 0.0056 | 0.0446 | 1 | |
Trichomonas vaginalis | chromobox protein, putative | 0.0047 | 0.02 | 0.0556 |
Loa Loa (eye worm) | heterochromatin protein 1 | 0.0079 | 0.1116 | 0.1432 |
Echinococcus multilocularis | sterol O acyltransferase 1 | 0.0264 | 0.6563 | 0.6563 |
Brugia malayi | Fli-1 protein | 0.0248 | 0.609 | 0.9399 |
Onchocerca volvulus | Heterochromatin protein 1 homolog | 0.0047 | 0.02 | 0.2851 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0104 | 0.187 | 1 |
Trichomonas vaginalis | chromobox protein, putative | 0.0047 | 0.02 | 0.0556 |
Trichomonas vaginalis | chromobox protein, putative | 0.0079 | 0.1116 | 0.5737 |
Echinococcus multilocularis | geminin | 0.0191 | 0.4421 | 0.4421 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Change (functional) | 0 % | Percent change in total cholesterol in cholic acid (0.5%)-cholesterol (1.5%)-peanut oil (5.5%)-fed rats (50 mg/kg was administered as the standard dose); No change | ChEMBL. | 8021920 |
clogP | = 7.11 | Calculated partition coefficient (clogP) | ChEMBL. | 8021920 |
IC50 (binding) | = 0.4 uM | In vitro inhibition of rat intestinal acyl coenzyme A:cholesterol acyltransferase using [1-14C]-oleolyl-CoA | ChEMBL. | 8021920 |
IC50 (binding) | = 0.4 uM | In vitro inhibition of rat intestinal acyl coenzyme A:cholesterol acyltransferase using [1-14C]-oleolyl-CoA | ChEMBL. | 8021920 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.